Share-based Payment Arrangement, Expense of Tracon Pharmaceuticals, Inc. from 31 Mar 2014 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tracon Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2014 to 30 Jun 2024.
  • Tracon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $339,000, a 32% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $1,705,000, a 12% decline year-over-year.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1,969,000, a 3.5% decline from 2022.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2,041,000, a 15% increase from 2021.
  • Tracon Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1,775,000, a 72% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Tracon Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $1,705,000 $339,000 -$163,000 -32% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,868,000 $383,000 -$101,000 -21% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,969,000 $490,000 +$13,000 +2.7% 01 Oct 2023 31 Dec 2023 10-K 05 Mar 2024 2023 FY
Q3 2023 $1,956,000 $493,000 +$12,000 +2.5% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,944,000 $502,000 -$33,000 -6.2% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $1,977,000 $484,000 -$64,000 -12% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $2,041,000 $477,000 -$37,000 -7.2% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $2,078,000 $481,000 -$20,000 -4% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $2,098,000 $535,000 +$118,000 +28% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $1,980,000 $548,000 +$205,000 +60% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 $1,775,000 $514,000 +$250,000 +95% 01 Oct 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
Q3 2021 $1,525,000 $501,000 +$261,000 +109% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $1,264,000 $417,000 +$154,000 +59% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q1 2021 $1,110,000 $343,000 +$76,000 +28% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 $1,034,000 $264,000 -$33,000 -11% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2023 2022 FY
Q3 2020 $1,067,000 $240,000 -$75,000 -24% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021 2021 Q3
Q2 2020 $1,142,000 $263,000 -$153,000 -37% 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
Q1 2020 $1,295,000 $267,000 -$329,000 -55% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q4 2019 $1,624,000 $297,000 -$326,000 -52% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
Q3 2019 $1,950,000 $315,000 -$359,000 -53% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $2,309,000 $416,000 -$248,000 -37% 01 Apr 2019 30 Jun 2019 10-Q 05 Aug 2020 2020 Q2
Q1 2019 $2,557,000 $596,000 -$110,000 -16% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q4 2018 $2,667,000 $623,000 -$173,000 -22% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $2,840,000 $674,000 -$123,000 -15% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $2,963,000 $664,000 -$131,000 -16% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019 2019 Q2
Q1 2018 $3,094,000 $706,000 -$100,000 -12% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019 2019 Q1
Q4 2017 $3,194,000 $796,000 +$51,000 +6.8% 01 Oct 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
Q3 2017 $3,143,000 $797,000 +$259,000 +48% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3
Q2 2017 $2,884,000 $795,000 -$148,000 -16% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 $3,032,000 $806,000 -$51,000 -6% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $3,083,000 $745,000 +$3,000 +0.4% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $3,080,000 $538,000 -$134,000 -20% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017 2017 Q3
Q2 2016 $3,214,000 $943,000 +$516,000 +121% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017 2017 Q2
Q1 2016 $2,698,000 $857,000 +$610,000 +247% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $2,088,000 $742,000 +$626,000 +540% 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
Q3 2015 $1,462,000 $672,000 +$615,000 +1079% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $847,000 $427,000 +$377,000 +754% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $470,000 $247,000 +$199,000 +415% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016 2016 Q1
Q4 2014 $271,000 $116,000 01 Oct 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
Q3 2014 $57,000 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015 2015 Q3
Q2 2014 $50,000 01 Apr 2014 30 Jun 2014 10-Q 06 Aug 2015 2015 Q2
Q1 2014 $48,000 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1

Tracon Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $1,969,000 -$72,000 -3.5% 01 Jan 2023 31 Dec 2023 10-K 05 Mar 2024 2023 FY
2022 $2,041,000 +$266,000 +15% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $1,775,000 +$741,000 +72% 01 Jan 2021 31 Dec 2021 10-K 05 Mar 2024 2023 FY
2020 $1,034,000 -$590,000 -36% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2023 2022 FY
2019 $1,624,000 -$1,043,000 -39% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2022 2021 FY
2018 $2,667,000 -$527,000 -16% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $3,194,000 +$111,000 +3.6% 01 Jan 2017 31 Dec 2017 10-K 28 Feb 2020 2019 FY
2016 $3,083,000 +$995,000 +48% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $2,088,000 +$1,817,000 +670% 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $271,000 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.